Epigenetically - Targeted Therapies for the Treatment of Hematological Malignancies

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|18|12|1757-1764

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.12, 2011-04, pp. : 1757-1764

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial [Hot Topic: Innovative Therapeutical Approaches for Hematological Malignancies Based on Molecular Targeted Therapies (Executive Editor: Giorgio Zauli) ]

By  

Current Pharmaceutical Design, Vol. 14, Iss. 21, 2008-07 ,pp. : 2022-2022

Bentham Science Publishers

Access to resources Recommend Favorite

Efficacy and Safety of the Combination of Docetaxel (Taxotere#174;) with Targeted Therapies in the Treatment of Solid Malignancies

By  

Current Drug Targets, Vol. 10, Iss. 10, 2009-10 ,pp. : 982-1000

Bentham Science Publishers

Access to resources Recommend Favorite

Exploring Old Drugs for the Treatment of Hematological Malignancies

By  

Current Medicinal Chemistry, Vol. 18, Iss. 10, 2011-04 ,pp. : 1509-1514

Bentham Science Publishers

Access to resources Recommend Favorite

MYC-mediated Synthetic Lethality for Treatment of Hematological Malignancies

By  

Current Cancer Drug Targets, Vol. 15, Iss. 1, 2015-01 ,pp. : 53-70

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors in the Treatment of Hematological Malignancies

By  

Mini Reviews in Medicinal Chemistry, Vol. 11, Iss. 6, 2011-06 ,pp. : 519-527

Bentham Science Publishers

Access to resources Recommend Favorite